Xeris Biopharma Holdings, Inc. XERS Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current)?
- Xeris Biopharma Holdings, Inc. (XERS) reported operating lease liabilities (current) of $6.27M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current) changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s operating lease liabilities (current) increased by 2.5% year-over-year, from $6.12M to $6.27M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.